Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 24, 2020 07:06 ET | Source: Algernon Pharmaceuticals

Algernon, 이펜프로딜 코로나19 인간 대상 임상시험의 한국 내 실시와 관련된 규제기관 및 윤리적 승인 획득

캐나다 밴쿠버, April 24, 2020 (GLOBE NEWSWIRE) -- 임상 단계 제약 개발사인 Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF)는 대한민국 식품의약품안전처로부터 NMDA 수용체 길항제로 당사가 약물 재창출 방식으로 개발 중인...
April 23, 2020 07:30 ET | Source: Algernon Pharmaceuticals

Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea

VANCOUVER, British Columbia, April 23, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage...
April 22, 2020 07:30 ET | Source: Algernon Pharmaceuticals

Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial

VANCOUVER, British Columbia, April 22, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
April 15, 2020 08:30 ET | Source: Algernon Pharmaceuticals

Algernon Receives Positive Feedback from U.S. FDA for New Ifenprodil Intravenous Formulation

VANCOUVER, British Columbia, April 15, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
April 13, 2020 11:34 ET | Source: Algernon Pharmaceuticals

Algernon CEO and CSO to be Featured on BioPub Webcast Hosted by Dr. KSS MD PhD

VANCOUVER, British Columbia, April 13, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage...
April 13, 2020 08:30 ET | Source: Algernon Pharmaceuticals

Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory Board

VANCOUVER, British Columbia, April 13, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
April 09, 2020 08:30 ET | Source: Algernon Pharmaceuticals

Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea

VANCOUVER, British Columbia, April 09, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
April 08, 2020 08:30 ET | Source: Algernon Pharmaceuticals

Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial

VANCOUVER, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
April 02, 2020 08:30 ET | Source: Algernon Pharmaceuticals

Algernon Provides Update on Phase 2 Human Testing of Ifenprodil for COVID-19

VANCOUVER, British Columbia, April 02, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
March 30, 2020 08:30 ET | Source: Algernon Pharmaceuticals

Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study

VANCOUVER, British Columbia, March 30, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...